|
Mutation Information
|
Mutation Site
|
M184I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
antiretroviral (ARV);tenofovir (TDF);darunavir (DRV);NRTIs;NNRTIs;PIs;INSTIs;etravirine (ETR);atazanavir (ATV) |
Literature Information
|
PubMed PMID
|
33329900
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
Journal of virus eradication |
|
Title
|
Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in a real-world setting. |
|
Author
|
Rolle CP,Nguyen V,Hinestrosa F,DeJesus E |
|
Evidence
|
On historical genotypic testing, the patient had an M184 V/I and K65R mutation with no INSTI or PI resistance-associated mutations (RAMs).
|
|
|
HIV Mutation Detail Information